Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (151-160 of 405) with videos related to

Pageof 41
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|December 13, 2005
Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsivenessVictor Serebruany, Alex Malinin, Wendy Ziai, et al.
Cardiology|April 25, 2008
New-onset atrial fibrillation in bacteremia is not associated with C-reactive protein, but is an indicator of increased mortality during hospitalizationIngvild A Kindem, Eva K Reindal, Astrid L Wester, et al.
The American Journal of Medicine|February 24, 2023
Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 YearVictor L Serebruany, Jean-Francois Tanguay, Milana L Gurvich, et al.
Cardiology|March 9, 2025
One-Hour Troponin Using a High-Sensitivity Point-of-Care Assay in Emergency Primary Care: The OUT-POC Pilot StudyTonje R Johannessen, Odd Martin Vallersnes, Anne Cecilie K Larstorp, et al.
Atherosclerosis|September 28, 2012
The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffnessKristin Angel, Sella Aarrestad Provan, Petter Mowinckel, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2009
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled studyKristin Angel, Sella Aarrestad Provan, Hanne Løvdahl Gulseth, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|November 6, 2022
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor dataEinar Heiberg, Henrik Engblom, Marcus Carlsson, et al.
The American Journal of Medicine|August 17, 2022
Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary SyndromeVictor L Serebruany, Jean-François Tanguay, Wiktor Kuliczkowski, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 20, 2018
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?Joseph Allencherril, Mahboob Alam, Glenn Levine, et al.
Heart and Vessels|September 20, 2007
Rheumatic mitral valve stenosis mimicking advanced lung cancerThomas von Lueder, Kjetil Steine, Tone Nerdrum, et al.
Pageof 41

Showing results (151-160 of 405) with videos related to

Sort By:
Pageof 41
Cerebrovascular Diseases (Basel, Switzerland)|December 13, 2005
Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsivenessVictor Serebruany, Alex Malinin, Wendy Ziai, et al.
Cardiology|April 25, 2008
New-onset atrial fibrillation in bacteremia is not associated with C-reactive protein, but is an indicator of increased mortality during hospitalizationIngvild A Kindem, Eva K Reindal, Astrid L Wester, et al.
The American Journal of Medicine|February 24, 2023
Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 YearVictor L Serebruany, Jean-Francois Tanguay, Milana L Gurvich, et al.
Cardiology|March 9, 2025
One-Hour Troponin Using a High-Sensitivity Point-of-Care Assay in Emergency Primary Care: The OUT-POC Pilot StudyTonje R Johannessen, Odd Martin Vallersnes, Anne Cecilie K Larstorp, et al.
Atherosclerosis|September 28, 2012
The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffnessKristin Angel, Sella Aarrestad Provan, Petter Mowinckel, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2009
Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled studyKristin Angel, Sella Aarrestad Provan, Hanne Løvdahl Gulseth, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|November 6, 2022
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor dataEinar Heiberg, Henrik Engblom, Marcus Carlsson, et al.
The American Journal of Medicine|August 17, 2022
Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary SyndromeVictor L Serebruany, Jean-François Tanguay, Wiktor Kuliczkowski, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 20, 2018
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?Joseph Allencherril, Mahboob Alam, Glenn Levine, et al.
Heart and Vessels|September 20, 2007
Rheumatic mitral valve stenosis mimicking advanced lung cancerThomas von Lueder, Kjetil Steine, Tone Nerdrum, et al.
Pageof 41